ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: white House Names Phillip Sharp To NCAB; Shine Re-appointed As IOM President

September 27, 1996

DCPC Faces Huge Out Year Costs Of Four Trials

February 15, 1991

President Obama Signs FDA User Fee Act Into Law

July 13, 2012

In Brief: Center wins $10 Million To coordinate Study; Albert Einstein Center Name Comprehensive

December 5, 1997

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014